StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Lithium Hydroxide → 2-[6-[(4-Tert-butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-8-yl]-2-methylpropanoic acid

HRID 1691446
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1691446
C[O:2][C:3](=[O:39])[C:4]([C:7]1[CH:8]=[CH:9][C:10]2[NH:16][C:15]3[N:17]=[C:18]([C:21]([F:24])([F:23])[F:22])[CH:19]=[CH:20][C:14]=3[CH2:13][N:12]([S:25]([C:28]3[CH:33]=[CH:32][C:31]([C:34]([CH3:37])([CH3:36])[CH3:35])=[CH:30][CH:29]=3)(=[O:27])=[O:26])[C:11]=2[CH:38]=1)([CH3:6])[CH3:5].[Li+].[OH-]>O.C1COCC1.C(#N)C>[C:34]([C:31]1[CH:30]=[CH:29][C:28]([S:25]([N:12]2[C:11]3[CH:38]=[C:7]([C:4]([CH3:6])([CH3:5])[C:3]([OH:39])=[O:2])[CH:8]=[CH:9][C:10]=3[NH:16][C:15]3[N:17]=[C:18]([C:21]([F:23])([F:22])[F:24])[CH:19]=[CH:20][C:14]=3[CH2:13]2)(=[O:26])=[O:27])=[CH:33][CH:32]=1)([CH3:35])([CH3:36])[CH3:37]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 2

HCID 3939Lithium HydroxideHCID 596187022-[6-[(4-tert-Butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-8-yl]-2-methylpropanoic acid methyl ester

Produkt 1

HCID 596186742-[6-[(4-Tert-butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-8-yl]-2-methylpropanoic acid

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 18694733
Acetonitrile tetrahydrofuran water
Lösungsmittel

Versuchsvorschrift

To the methyl ester (92 mg, 0.16 mmol) of Example 373 in 3 mL of H2O/THF/acetonitrile (1:1:1) was added LiOH (16 mg, 0.65 mmol). After stirring at rt for 48 hrs, the reaction was quenched with aqueous NH4Cl (25 mL) and the product was extracted with EtOAc (60 mL). The extracts were washed with water (30 mL) and brine (30 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified on silica gel column eluting with 20-50% EtOAc in hexanes to afford the title compound. 1H NMR (500 MHz, CD3OD): δ 7.61 (1H, d), 7.46 (1H, s), 7.24 (1H, d), 7.17 (2H, d), 7.03 (1H, d), 6.93 (1H, d), 6.91 (2H, d), 1.58 (6H, s), 1.22 (9H, s). LCMS: m/e 548.2 (M+H)+.

Aufarbeitung

  1. customthe reaction was quenched with aqueous NH4Cl (25 mL)
  2. extractionthe product was extracted with EtOAc (60 mL)
  3. washThe extracts were washed with water (30 mL) and brine (30 mL)
  4. dry with materialdried over MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. customThe residue was purified on silica gel column
  8. washeluting with 20-50% EtOAc in hexanes

Quellen und Nachweise

ORD-Eintrag
ord-224f0abf0f4e4f32aad66088522e6a02
Quelldatensatz
uspto-grants-2012_04
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08153626B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion